ARKG ARK Genomic Revolution ETF
US$51.43
-6.61%
Latest close
Trend channel, buy level and 3-month target. Information only, not financial advice.
Inside the channel · 18-month channel rising
Price is between the lines.
- 18-month channel
- US$48.90 – US$60.42 · rising, +67% a year
- Price in channel
- 22% (0% = floor, 100% = ceiling)
- Ceiling overhead
- US$60.42
- Turns bearish below
- US$48.90
- Published levels
- Buy and target are not from this channel — see below.
Price history, with the path projected 3 months forward
Updated 2:30 AM ET (8 h ago)
- Daily close
- Upper trend line (18 months)
- Lower trend line (18 months)
- Dashed after today: projected 3 months
- Our buy
- Our target
Suggested path
Buy at or below
US$47.53
level as at 1 Dec 2026
Our target
US$53.24
by 7 Nov 2026
Projected move
12.0%
gross, before costs
Price is between our buy and target.
Target: ARKG's usual move size (12.0%), the best return per day on this path.
This move size: reached in 36% of 22 past stretches, typically in 29 days. (0.41% per day)
- Upper line touches
- 3
- Lower line touches
- 3
- Fit confidence
- 53%
- Fitted
- 1 Nov 2026
Company information
About ARK Genomic Revolution ETF
ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund, a series of ARK ETF Trust registered with the SEC (series S000042975), listed on BATS and quoted in USD.
- Country
- United States
Trend lines are fitted to past swing highs and lows and may not continue. Information only, not financial advice.